Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0V2WO
|
||||
Former ID |
DIB002264
|
||||
Drug Name |
PC-DAC:Insulin
|
||||
Synonyms |
Capsulin; Intesulin; Macrulin; Nodlin; SuliXen; AERx Diabetes Management System; AERx iDMS; Capsulin IR; Capsulin OAD; Capsulin insulin replacement; Insulin tregopil; Ultrafast Insulin program; HIM2; AERx (insulin); AT-1391; AT-2391; Analog-PH20; CADDYS (insulin); CJC-1530; CJC-1531; CJC-1575; CJC-1576; Capsulin oral anti-diabetic; DTY-001; GW-843362; GW-843362M; Hexyl insulin monoconjugate, Nobex; IN-105; Inhaled insulin, Andaris; Insulin-PH20; Intesulin-1; Intesulin-IVE; NB-058; NIN-058; NN-1998; ORMD-0801; Oral insulin, Emisphere; Oral insulin, Nobex; PC-Insulin; Inhaled insulin, QDose/BMS; Inhaled insulin, Quadrant/MicroDose; Insulin (inhaled), Aradigm; Insulin (inhaled), QDose; Insulin (inhaled),Translational Research; Insulin (oral), Biocon; Insulin (oral), Coremed; Insulin (oral), Protein Delivery Inc; Insulin (pulmonary), Translational Research; MicroPor (insulin), Altea
|
||||
Indication | Type 1 diabetes [ICD9: 250; ICD10:E10] | Phase 3 | [521936] | ||
Company |
Lipoxen plc; Aradigm; Translational Research Ltd; Diabetology Ltd; Coremed Inc; Nobex Corp; Altea Therapeutics; ConjuChem Biotechnologies Inc; Bioglan Pharmaceuticals Co; Epic Therapeutics Inc; NOD Pharmaceuticals Inc; Andaris Group Ltd; Emisphere Technologies Inc; halozyme therapeutics
|
||||
Target and Pathway | |||||
Target(s) | insulin | Target Info | Modulator | [544109], [544133] | |
KEGG Pathway | Ras signaling pathway | ||||
Rap1 signaling pathway | |||||
cGMP-PKG signaling pathway | |||||
HIF-1 signaling pathway | |||||
FoxO signaling pathway | |||||
Oocyte meiosis | |||||
Regulation of autophagy | |||||
mTOR signaling pathway | |||||
PI3K-Akt signaling pathway | |||||
AMPK signaling pathway | |||||
Regulation of actin cytoskeleton | |||||
Insulin signaling pathway | |||||
Insulin secretion | |||||
Ovarian steroidogenesis | |||||
Progesterone-mediated oocyte maturation | |||||
Prolactin signaling pathway | |||||
Type II diabetes mellitus | |||||
Non-alcoholic fatty liver disease (NAFLD) | |||||
Type I diabetes mellitus | |||||
Maturity onset diabetes of the young | |||||
Aldosterone-regulated sodium reabsorption | |||||
Prostate cancer | |||||
WikiPathways | Senescence and Autophagy in Cancer | ||||
Differentiation Pathway | |||||
Insulin Processing | |||||
Nanoparticle triggered autophagic cell death | |||||
Cardiac Progenitor Differentiation | |||||
Adipogenesis | |||||
AGE/RAGE pathway | |||||
SREBP signalling | |||||
Cori Cycle | |||||
Synthesis, Secretion, and Deacylation of Ghrelin | |||||
Signaling by Insulin receptor | |||||
Regulation of beta-cell development | |||||
Integration of energy metabolism | |||||
Folate Metabolism | |||||
Vitamin B12 Metabolism | |||||
Selenium Micronutrient Network | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.